首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1880篇
  免费   67篇
  国内免费   2篇
电工技术   10篇
综合类   1篇
化学工业   328篇
金属工艺   36篇
机械仪表   106篇
建筑科学   106篇
矿业工程   6篇
能源动力   38篇
轻工业   102篇
水利工程   31篇
石油天然气   11篇
无线电   92篇
一般工业技术   311篇
冶金工业   398篇
原子能技术   12篇
自动化技术   361篇
  2023年   13篇
  2022年   20篇
  2021年   47篇
  2020年   33篇
  2019年   29篇
  2018年   44篇
  2017年   45篇
  2016年   50篇
  2015年   30篇
  2014年   49篇
  2013年   102篇
  2012年   114篇
  2011年   116篇
  2010年   92篇
  2009年   72篇
  2008年   112篇
  2007年   85篇
  2006年   109篇
  2005年   63篇
  2004年   39篇
  2003年   28篇
  2002年   37篇
  2001年   23篇
  2000年   28篇
  1999年   31篇
  1998年   74篇
  1997年   46篇
  1996年   28篇
  1995年   24篇
  1994年   21篇
  1993年   29篇
  1992年   18篇
  1991年   18篇
  1990年   16篇
  1989年   13篇
  1988年   10篇
  1987年   16篇
  1986年   20篇
  1985年   21篇
  1984年   25篇
  1983年   18篇
  1982年   10篇
  1981年   17篇
  1980年   10篇
  1979年   13篇
  1978年   13篇
  1977年   17篇
  1976年   20篇
  1975年   7篇
  1973年   6篇
排序方式: 共有1949条查询结果,搜索用时 15 毫秒
1.
Loss of β-cell mass and function can lead to insufficient insulin levels and ultimately to hyperglycemia and diabetes mellitus. The mainstream treatment approach involves regulation of insulin levels; however, approaches intended to increase β-cell mass are less developed. Promoting β-cell proliferation with low-molecular-weight inhibitors of dual-specificity tyrosine-regulated kinase 1A (DYRK1A) offers the potential to treat diabetes with oral therapies by restoring β-cell mass, insulin content and glycemic control. GNF4877, a potent dual inhibitor of DYRK1A and glycogen synthase kinase 3β (GSK3β) was previously reported to induce primary human β-cell proliferation in vitro and in vivo. Herein, we describe the lead optimization that lead to the identification of GNF4877 from an aminopyrazine hit identified in a phenotypic high-throughput screening campaign measuring β-cell proliferation.  相似文献   
2.
Breast cancer is the most frequently diagnosed cancer in women worldwide. The disease and its treatments exert profound effects on an individual’s physical and mental health. There are many factors that impact an individual’s risk of developing breast cancer, their response to treatments, and their risk of recurrence. The community of microorganisms inhabiting the gastrointestinal tract, the gut microbiota, affects human health through metabolic, neural, and endocrine signaling, and immune activity. It is through these mechanisms that the gut microbiota appears to influence breast cancer risk, response to treatment, and recurrence. A disrupted gut microbiota or state of ‘dysbiosis’ can contribute to a biological environment associated with higher risk for cancer development as well as contribute to negative treatment side-effects. Many cancer treatments have been shown to shift the gut microbiota toward dysbiosis; however, the microbiota can also be positively manipulated through diet, prebiotic and probiotic supplementation, and exercise. The objective of this review is to provide an overview of the current understanding of the relationship between the gut microbiota and breast cancer and to highlight potential strategies for modulation of the gut microbiota that could lead to improved clinical outcomes and overall health in this population.  相似文献   
3.
4.
Wan  Huan  Wang  Hui  Scotney  Bryan  Liu  Jun  Ng  Wing W. Y. 《Multimedia Tools and Applications》2020,79(39-40):29327-29352
Multimedia Tools and Applications - In many real-world classification problems there exist multiple subclasses (or clusters) within a class; in other words, the underlying data distribution is...  相似文献   
5.
Rats given medial frontal lesions on Postnatal Day 1 or Day 10 were trained on the Morris water task on Days 19–21 or Days 56–58. The operated groups were equally impaired at the water task on Days 19–21, but the Day 10 rats had recovered by 56 days. Dendritic arborization and spine density were analyzed in parietal layer II–III pyramidal cells. At Day 60, but not at Day 22, the Day 10 animals had more dendritic spines per unit dendritic length than did the controls or Day 1 rats. Thus, there was functional recovery rather than sparing after frontal lesions at 10 days, and the recovery was correlated with an increase in dendritic spines. (PsycINFO Database Record (c) 2010 APA, all rights reserved)  相似文献   
6.
7.
8.
The hydrogen permeance of 1 mm-thick Pd80wt%Cu foils was measured in the presence of equimolar mixtures of H2 with CO, CO2 or H2O over the temperature and total pressure ranges of 623–1,173 K and 0.62–2.86 MPa, respectively. In all cases, permeance losses at 623 and 738 K were very modest. At higher temperatures, more significant decreases in membrane permeance were observed with the highest reduction of about 50% occurring when macroscopic carbon deposition occurred on the membrane surface during H2–CO exposure at 908 K. The more worrisome effects of exposure to these gases, however, were the micron-scale surface defects observed at 908 and 1,038 K. Although the 1 mm thick disk membranes retained their mechanical integrity, such defects could cause catastrophic failure of ultra-thin, Pd–Cu membranes (1–5 μm thick) deposited on porous substrates.  相似文献   
9.
We apply appropriately enhanced transition matrix and multicanonical methods to communication systems. Our procedure not only predicts time-independent quantities such as the bit-error-probability but can also be applied to dynamic effects such as the distribution of fading times.  相似文献   
10.
Dopaminergic blocking agents have been known to suppress intracranial self-stimulation, but whether the suppression results from a reduction in the rewarding value of stimulation or from motor deficits has remained controversial. We have resolved this controversy by developing an operant technique minimally dependent on motor activity; rats were trained to perform a bar-holding response for 3s or to produce hippocampal theta waves for 3s when the bar was retracted. Decamethonium bromide (a muscle relaxant) reduced bar holding without affecting theta production for brain stimulation. Pimozide (a dopaminergic blocking-agent) reduced both bar holding and theta production for stimulation, though rats were still capable of making the theta response at a rate comparable to the preinjection rate. Dopaminergic blocking at low doses reduces the rewarding value of brain stimulation at the level of the lateral hypothalamus. The method described in this report has wide applicability. (PsycINFO Database Record (c) 2010 APA, all rights reserved)  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号